SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-058436
Filing Date
2022-09-23
Accepted
2022-09-23 16:53:32
Documents
14
Period of Report
2022-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166253-8k_inmedpharma.htm   iXBRL 8-K 30012
2 NEWS RELEASE, DATED SEPTEMBER 23, 2022 ea166253ex99-1_inmedpharma.htm EX-99.1 108416
3 GRAPHIC image_001.jpg GRAPHIC 16114
  Complete submission text file 0001213900-22-058436.txt   350657

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20220923.xsd EX-101.SCH 3233
5 XBRL LABEL FILE inm-20220923_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20220923_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea166253-8k_inmedpharma_htm.xml XML 3609
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221262837
SIC: 2834 Pharmaceutical Preparations